검색어: aripiprazola (크로아티아어 - 영어)

shizofrenija kod oralno primijenjenog aripiprazola
schizophrenia with oral aripiprazole

jedan ml sadrži 1 mg aripiprazola.
each ml oral solution contains 1 mg of aripiprazole.

jedna tableta sadrži 15 mg aripiprazola
each tablet contains 15 mg of aripiprazole

jedna tableta sadrži 10 mg aripiprazola.
each tablet contains 10 mg aripiprazole.

jedan ml sadrži 7,5 mg aripiprazola.
each ml contains 7.5 mg aripiprazole.

potencijal aripiprazola da utječe na druge lijekove
potential for aripiprazole to affect other medicinal products

jedna napunjena štrcaljka sadrži 300 mg aripiprazola.
each pre-filled syringe contains 300 mg aripiprazole.

jedna raspadljiva tableta za usta sadrži 10 mg aripiprazola.
each orodispersible tablet contains 10 mg of aripiprazole.

nema odgovarajućih i dobro kontroliranih ispitivanja aripiprazola u trudnica.
there are no adequate and well-controlled trials of aripiprazole in pregnant women.

bočica sadrži 9,75 mg (1,3 ml) aripiprazola.
a vial contains 9.75 mg (1.3 ml) aripiprazole.

doza aripiprazola mora se udvostručiti kad se uz aripiprazolistodobno primjenjuje karbamazepin.
aripiprazole dose should be doubled when concomitant administration of aripiprazole occurs with carbamazepine.

dozu aripiprazola treba smanjiti na približno upola manju od propisane.
aripiprazole dose should be reduced to approximatively one-half of its prescribed dose.

bolesnici kojima se dalo previše aripiprazola imali su sljedeće simptome:
patients who have been given too much aripiprazole have experienced the following symptoms:

farmakokinetika aripiprazola nakon primjene jedne doze bila je linearna i proporcionalna dozi.
the single- dose pharmacokinetics of aripiprazole was linear and dose-proportional.

aripiprazol accord 10 mg tablete: jedna tableta sadrži 10 mg aripiprazola.
aripiprazole accord 10 mg tablets: each tablet contains 10 mg of aripiprazole.

nisu dostupni podaci o dugotrajnoj djelotvornosti i sigurnosti aripiprazola u ovom promjenjivom poremećaju.
no long term data are available with regard to the efficacy and the safety of aripiprazole in this fluctuating disorder.

kad se istodobno s aripiprazolom primjenjuju jaki induktori cyp3a4, doza aripiprazola mora se povisiti.
when concomitant administration of potent cyp3a4 inducers with aripiprazole occurs, the aripiprazole dose should be increased.

doza aripiprazola mora se smanjiti na otprilike polovicu propisane doze kad se primjenjuje istodobno s kinidinom.
aripiprazole dose should be reduced to approximately one-half of its prescribed dose when concomitant administration of aripiprazole with quinidine occurs.

razine prolaktina evaluirane su u svim ispitivanjima svih doza aripiprazola (n = 28 242).
prolactin levels were evaluated in all trials of all doses of aripiprazole (n = 28,242).

doza se također može smanjiti kod bolesnika koji uzimaju određene druge lijekove koji usporavaju razgradnju aripiprazola u tijelu.
the dose may also need to be lowered in patients who are taking certain other medicines that slow the breakdown of aripiprazole in the body.